Lantheus Holdings, Inc

LNTHNASDAQUSD
93.91 USD
2.76 (2.86%)AT CLOSE (11:59 AM EDT)
93.89
0.02 (0.02%)
POST MARKET (AS OF 06:23 PM EDT)
Post Market
AS OF 06:23 PM EDT
93.89
0.02 (0.02%)
🔴Market: CLOSED
Open?$96.12
High?$96.68
Low?$93.29
Prev. Close?$96.67
Volume?926.9K
Avg. Volume?851.6K
VWAP?$94.42
Rel. Volume?1.09x
Bid / Ask
Bid?$80.33 × 100
Ask?$108.03 × 100
Spread?$27.70
Midpoint?$94.18
Valuation & Ratios
Market Cap?6.1B
Shares Out?65.1M
Float?63.5M
Float %?97.8%
P/E Ratio?21.91
P/B Ratio?5.04
EPS?$4.29
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Employees
1.2K
Market Cap
6.1B
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed
2015-06-25
Address
331 TREBLE COVE ROAD
NORTH BILLERICA, MA 01862
Phone: 978 671-8001
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.83Strong
Quick Ratio?2.64Strong
Cash Ratio?1.50Strong
Debt/Equity?0.47Low
ValuationFAIRLY VALUED
Score
72/100
P/E?
21.9FAIR
P/B?
5.04FAIR
P/S?
3.95FAIR
P/FCF?
16.2CHEAP
EV/EBITDA?
16.8FAIR
EV/Sales?
4.00FAIR
Returns & Efficiency
ROE?
23.0%STRONG
ROA?
11.9%STRONG
Cash Flow & Enterprise
FCF?$377.1M
Enterprise Value?$6.2B
Fundamentals ratios updated end of day